Abilita Therapeutics
PrivateLast Round
Grant
Sep 15, 2023
Total Funding Raised
$1.43M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Abilita Therapeutics is a biotechnology company that discovers and develops therapeutics targeting challenging membrane proteins like GPCRs, ion channels, and transporters.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abilita Therapeutics Comparables
Compare Abilita Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salipro Biotech AB | 86% | |
| Confo Therapeutics | 86% | |
| Maxion Therapeutics | 84% |
Abilita Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2023 | ||||
| VC Round | Feb 21, 2023 | ||||
| Grant | Sep 1, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Sep 20, 2016 |
Abilita Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Two Bear Capital | VC Round |
| National Institute on Aging | Grant |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 44% MoM, reaching 2.6K.
- Jul 30, 2026
Monthly visitors increased 65% MoM.
Abilita Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abilita Therapeutics's valuation, stock price, and market status.
Is Abilita Therapeutics a public or private company?
Abilita Therapeutics is a private company.
What is the current stock price of Abilita Therapeutics?
Abilita Therapeutics is a private company, so its shares have no public market price. Caplight tracks Abilita Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abilita Therapeutics worth (valuation)?
Valuation information for Abilita Therapeutics is not publicly available.
Can I buy Abilita Therapeutics stock?
Abilita Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abilita Therapeutics's last funding round?
Abilita Therapeutics's most recent funding round was Grant on September 15, 2023.
Who are the main investors in Abilita Therapeutics?
Key investors in Abilita Therapeutics include Two Bear Capital.
Will Abilita Therapeutics IPO soon?
No public IPO plans have been announced for Abilita Therapeutics.
How can I track Abilita Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Abilita Therapeutics's shares on secondary markets.